Invention Grant
- Patent Title: EP2 and EP4 agonists as agents for the treatment of influenza a viral infection
-
Application No.: US13073889Application Date: 2011-03-28
-
Publication No.: US08980944B2Publication Date: 2015-03-17
- Inventor: Daryl Faulds , William J. Guilford , Wolfgang Seifert
- Applicant: Daryl Faulds , William J. Guilford , Wolfgang Seifert
- Applicant Address: US CA San Francisco
- Assignee: Gemmus Pharma Inc.
- Current Assignee: Gemmus Pharma Inc.
- Current Assignee Address: US CA San Francisco
- Agency: Weaver Austin Villeneuve & Sampson LLP
- Agent Tom Hunter
- Main IPC: A61K31/34
- IPC: A61K31/34 ; A61K31/35 ; A61K31/215 ; A61K31/5575 ; A61K31/5578 ; A61K31/5585 ; A61K31/343
Abstract:
The present invention is directed to the use of EP2 and/or EP4 agonists as therapeutics for the treatment of diseases associated with influenza A viruses, such as for example H5N1 and mutations thereof.
Public/Granted literature
- US20120190739A1 EP2 AND EP4 AGONISTS AS AGENTS FOR THE TREATMENT OF INFLUENZA A VIRAL INFECTION Public/Granted day:2012-07-26
Information query
